Exploring the COVID-created rise of DTP clinical trials, Ireland's role as a global pharma leader and QuickSTAT's commitment to the market.
Hear Jay Dexheimer, Neil Peirson and John Sabo discuss how our logistics expertise delivers for our customers and their patients.
Whether for life-changing medical procedures or critical research – QuickSTAT’s Donation & Testing Logistics solutions deliver.
QuickSTAT’s Michael Sweeney explains why Advanced Therapies Weeks is so critical as the cell and gene therapy industry grows and changes.
Allison Rickman shares how we plan for the unexpected. Read more.
Michael Sweeney, QuickSTAT’s Global Head of Strategy, CGT & DTP, shares his thoughts about the GCSG organization and its role as an important educational and networking event.
QuickSTAT’s Kathy Gerson’s quote captures our commitment to our clients. And as the cell and gene therapy market continues to grow and evolve, we need to evolve with it. That may bring new logistics challenges—and QuickSTAT will be prepared to overcome them.
Getting time- and temperature-sensitive cell and gene therapies to patients is more than critical—it can be lifesaving. Here’s how QuickSTAT’s 24/7 services deliver.
A “thank you!” message from the QuickSTAT team to clients who joined a June 2025 gathering of thought leaders in the advanced therapies’ community.
One of QuickSTAT's thought leaders, Greg Walters, shares insights on what's driving the growth of clinical trials in Australia.
Bringing new cell and gene therapies to market can be complicated. Find out how QuickSTAT can help optimize logistics supply chains.
:format(webp))
